InflaRx N.V. (IFRX) income statement
IFRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.04−0.05 (-4.59%)
Close on Nov 20, 2026Market cap $75.18MP/E –Yield –
InflaRx N.V. financial ratios
See a number that looks wrong?
Close on Nov 20, 2026Market cap $75.18MP/E –Yield –
See a number that looks wrong?
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Margins | ||||||||||||
| Gross margin | -24,677.9% | -1,900.8% | -743.7% | – | – | – | – | – | – | – | – | – |
| Operating margin | – | – | -71,182.1% | – | – | – | – | – | – | – | – | – |
| Pre-tax margin | -155,540.2% | -27,781.8% | -67,630.7% | – | – | – | – | – | – | – | – | – |
| Returns on capital | ||||||||||||
| Return on invested capital | – | – | – | – | -47.6% | – | – | – | – | – | – | – |
| Return on capital employed | – | – | -46.6% | -32.9% | -51.6% | – | – | – | – | – | – | – |
| Return on total capital | – | – | – | – | -45.2% | – | – | – | – | – | – | – |
| NOPAT | – | – | -35.48M | -25.47M | -37.63M | – | – | – | – | – | – | – |
| Cash flow quality | ||||||||||||
| OCF / Sales | -120,399.3% | -29,288.2% | -59,935.9% | – | – | – | – | – | – | – | – | – |
| Efficiency | ||||||||||||
| Asset turnover | 0.00 | 0.00 | 0.00 | – | – | – | – | – | – | – | – | – |
| Fixed asset turnover | 0.11 | 0.61 | 0.20 | – | – | – | – | – | – | – | – | – |
| Payables turnover | 0.87 | 0.28 | 0.06 | – | – | – | – | – | – | – | – | – |
| Days payables outstanding | 421.7 | 1,285.7 | 5,815.8 | – | – | – | – | – | – | – | – | – |
| Inventory turnover | – | 0.36 | 0.05 | – | – | – | – | – | – | – | – | – |
| Days inventory outstanding | – | 1,004.9 | 7,795.5 | – | – | – | – | – | – | – | – | – |
| Liquidity | ||||||||||||
| Current ratio | 4.13 | 5.06 | 6.50 | 7.48 | 5.10 | 8.54 | 8.46 | 20.39 | 26.01 | 16.83 | – | – |
| Quick ratio | 4.13 | 4.57 | 5.82 | 7.48 | 5.10 | 8.54 | 8.46 | 20.39 | 26.01 | 16.83 | – | – |
| Cash ratio | 1.23 | 1.30 | 0.76 | 1.25 | 1.40 | 2.57 | 2.36 | 7.14 | 25.87 | 16.68 | – | – |
| Working capital | 40.65M | 57.49M | 92.62M | 84.39M | 76.92M | 76.19M | 104.93M | 150.40M | 119.21M | 27.64M | – | – |
| Net current asset value | 39.97M | 57.05M | 91.84M | 83.36M | 75.82M | 75.93M | 104.56M | 150.34M | 119.20M | -25.83M | – | – |
| Leverage | ||||||||||||
| Total debt | – | – | – | – | 0 | – | – | – | – | – | – | – |
| Net debt | – | – | – | – | -26.25M | – | – | – | – | – | – | – |
| Debt / Equity | – | – | – | – | 0.00 | – | – | – | – | – | – | – |
| Debt ratio | – | – | – | – | 0.00% | – | – | – | – | – | – | – |
| Assets to equity | 7.70 | 10.22 | 16.28 | 14.11 | 1.19 | 1.13 | 1.13 | 1.05 | 1.04 | -1.15 | – | – |
| Long-term debt to assets | – | – | – | – | 0.00% | – | – | – | – | – | – | – |
| Long-term debt to equity | – | – | – | – | 0.00 | – | – | – | – | – | – | – |
| Total debt / Capitalization | – | – | – | – | 0.00% | – | – | – | – | – | – | – |
| Long-term debt / Capitalization | – | – | – | – | 0.00% | – | – | – | – | – | – | – |
| Intangibles to total assets | – | – | – | 0.14% | 0.19% | 0.40% | 0.37% | 0.14% | 0.03% | 0.02% | – | – |
| Interest coverage | ||||||||||||
| EBIT / Interest expense | – | – | -1,260.47 | -712.44 | -1,923.16 | – | – | – | – | – | – | – |
| Per share | ||||||||||||
| Revenue per share | 0.0004 | 0.0028 | 0.0011 | – | – | – | – | – | – | – | – | – |
| EPS (basic) | -0.68 | -0.78 | -0.78 | -0.67 | -1.10 | -1.26 | -2.05 | -1.19 | -2.58 | -3.80 | -2.10 | – |
| EPS (diluted) | -0.68 | -0.78 | -0.78 | -0.67 | -1.10 | -1.26 | -2.05 | -1.19 | -2.58 | -3.80 | -2.10 | – |
| Book value per share | 0.11 | 0.13 | 0.13 | 0.16 | 2.53 | 2.88 | 4.12 | 6.03 | 12.69 | -10,871.58 | – | – |
| Tangible book value per share | 0.11 | 0.13 | 0.13 | 0.16 | 2.52 | 2.86 | 4.10 | 6.02 | 12.69 | -10,873.69 | – | – |
| Cash per share | 0.24 | 0.31 | 0.23 | 0.37 | 0.63 | 0.96 | 1.27 | 2.21 | 13.10 | 12,321.94 | – | – |
| Operating cash flow per share | -0.52 | -0.82 | -0.69 | -0.76 | -0.96 | -1.35 | -1.66 | -0.86 | -1.29 | -2,112.57 | – | – |
| Valuation at period end | ||||||||||||
| Market cap | 59.51M | 135.70M | 72.06M | 129.05M | 128.83M | 130.80M | 99.38M | 342.26M | 49.51K | – | – | – |
| Enterprise value | 44.25M | 115.88M | 50.47M | 114.86M | 99.44M | 90.28M | 38.68M | 201.03M | -34.95M | – | – | – |
| P/S | 2,029x | 819x | 1,142x | – | – | – | – | – | – | – | – | – |
| P/B | 8.3x | 18.2x | 9.8x | 17.8x | 1.2x | 1.7x | 0.9x | 2.3x | 0.0x | – | – | – |
| P/TBV | 8.3x | 18.2x | 9.8x | 18.1x | 1.2x | 1.7x | 0.9x | 2.3x | 0.0x | – | – | – |
| P/Gross profit | -8.2x | -43.1x | -154x | – | – | – | – | -9.1x | -0.0x | – | – | – |
| P/OCF | -1.7x | -2.8x | -1.9x | -3.8x | -3.2x | -3.6x | -2.3x | -15.9x | -0.0x | – | – | – |
| EV/Sales | 1,509x | 699x | 800x | – | – | – | – | – | – | – | – | – |
| EV/Gross profit | -6.1x | -36.8x | -108x | – | – | – | – | -5.3x | 1.8x | – | – | – |
| EV/OCF | -1.3x | -2.4x | -1.3x | -3.4x | -2.5x | -2.5x | -0.9x | -9.3x | 2.9x | – | – | – |
| Shareholder yield | ||||||||||||
| Debt paydown yield | 0.60% | 0.29% | 0.52% | 0.28% | 0.28% | 0.28% | 0.30% | 0.00% | 0.00% | – | – | – |
| Cost structure | ||||||||||||
| R&D to revenue | 87,691.5% | 21,330.7% | 65,025.8% | – | – | – | – | – | – | – | – | – |
| SG&A to revenue | 54.4% | 25.0% | 150.9% | – | – | – | – | – | – | – | – | – |
| Stock-based comp to revenue | 15,153.4% | 2,452.4% | 5,412.2% | – | – | – | – | – | – | – | – | – |
| Growth | ||||||||||||
| Revenue 1Y growth | -82.3% | 162.8% | – | – | – | – | – | – | – | – | – | – |
| Gross profit 1Y growth | -129.7% | -571.7% | – | – | – | – | – | -93.4% | -174.5% | – | – | – |
| EBIT 1Y growth | – | – | -39.3% | 32.3% | – | – | – | – | – | – | – | – |
| Diluted EPS 1Y growth | 12.8% | 0.00% | -16.4% | 39.1% | 12.7% | 38.5% | -72.3% | 53.9% | 32.1% | -81.0% | – | – |
| Operating cash flow 1Y growth | 27.3% | -28.4% | -12.1% | 15.5% | -9.3% | 15.5% | -100.5% | -77.3% | -143.4% | -50.9% | – | – |
| Total assets 1Y growth | -27.4% | -36.8% | 17.4% | -18.2% | 41.9% | -27.4% | -23.6% | 28.2% | 320.8% | – | – | – |
| Total assets 3Y CAGR | -18.6% | -15.3% | 10.9% | -5.6% | -7.7% | -10.8% | 60.3% | – | – | – | – | – |
| Total assets 5Y CAGR | -8.9% | -9.0% | -5.5% | -3.8% | 33.5% | – | – | – | – | – | – | – |
| Total equity 1Y growth | -3.6% | 0.79% | 1.7% | -93.1% | – | – | – | – | – | – | – | – |
| Total equity 3Y CAGR | -0.40% | -58.7% | – | – | – | – | – | – | – | – | – | – |
Every figure here is calculated from standardized financial statements — hover a row name for the formula — not reported by the company. Valuation multiples use the closing price at the end of that period, not today's price.